相关实验视频

Updated: May 5, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

细胞内膜网膜应激和氧化合成酶的表达心力衰竭与保存和减少喷射分数 - 试点研究

Karol Momot¹, Małgorzata Wojciechowska², Kamil Krauz¹

¹Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Poland.

Cardiology journal

|October 3, 2024

概括

保存喷射分数 (HFpEF) 的心力衰竭显示出更高的可诱导氧化合成酶 (iNOS) 水平,而减少喷射分数 (HFrEF) 的心力衰竭则表现出更突出的内质网膜 (ER) 应力. 这项试点研究比较了HFpEF和HFrEF中的这些标志物.

科学领域:

心脏病学心脏病学
分子生物学分子生物学
病理生理学病理生理学

背景情况:

展开的蛋白质反应 (UPR),内质网膜 (ER) 应激,和可诱导的氧化合成酶 (iNOS) 都与心力衰竭有关.
它们在心力衰竭中所扮演的特定角色和相对意义与减少喷射率 (HFrEF) 仍然不太清楚.
这项研究解决了在HFpEF和HFrEF之间比较这些分子标记物的有限数据.

研究的目的:

为了比较HFpEF和HFrEF患者之间循环中的葡萄糖调节蛋白78kDa (GRP78),ER压力标志物和所有氧化合成酶 (NOS) 异型的水平.
调查这些标志物与患者临床特征之间的相关性.

主要方法:

试点研究涉及42名HFpEF和38名HFrEF患者.
收集的临床和心声回声数据,以及基本的实验室测试.
使用ELISA量化循环中的iNOS,内皮NOS (eNOS),神经元NOS (nNOS) 和GRP78.8的水平.

主要成果:

与HFrEF患者相比,HFpEF患者表现出较低的GRP78和更高的iNOS水平 (P=0.023,P<0.0001).
在HFpEF中,较低的eGFR与较高的nNOS和eNOS水平相关 (P=0.049,P=0.035).
在HFrEF中,糖尿病与高nNOS相关 (P=0.041),eNOS与nNOS正相关 (ρ=0.86,P<0.0001).

结论:

HFpEF的特点是更明显的iNOS过度表达.
HFrEF 显示出更显著的 ER 压力.
这些发现表明,HFpEF和HFrEF背后存在着不同的分子途径.

关键词:

细胞内膜网膜的压力应激心力衰竭与保存的喷射分数的心脏衰竭心力衰竭与减少的喷射分数心力衰竭化压力是一种化压力.氧化应激是一种氧化应激.

更多相关视频

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Published on: June 29, 2014

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...